A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Abbott
Related studies linked through entity extraction aliases.
A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
- Status
- TERMINATED
- Phase
- PHASE4
Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Lupron Depot In The Treatment of Central Precocious Puberty
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands
- Status
- COMPLETED
- Phase
- PHASE1
Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults
- Status
- COMPLETED
- Phase
- PHASE3
Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Adalimumab in Adult Japanese Subjects With Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing
- Status
- COMPLETED
- Phase
- PHASE3
Paricalcitol Injection Phase II Trial
- Status
- COMPLETED
- Phase
- PHASE2
Pediatric Switch Study for Children and Adolescent Patients With Epilepsy
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy
- Status
- COMPLETED
- Phase
- PHASE3